Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older

Summary

The present study aims to evaluate safety and immunogenicity of one dose of a commercially available Surface Antigen, Inactivated Influenza Vaccine, Formulation 2006-2007, in non-elderly adult and elderly subjects.

Timeline

Start

2006-10

Primary completion

—

Completion

—

Outcome

Outcome not reported

Stopped: “Lack of Vaccine Supplies”

Drugs

Indications